ACADIA Pharmaceuticals, Inc. (ACAD)
22.57
+1.09
(+5.07%)
USD |
NASDAQ |
May 07, 16:00
22.57
0.00 (0.00%)
After-Hours: 20:00
ACADIA Pharmaceuticals Research and Development Expense (Annual) : 328.80M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Insmed, Inc. | 771.09M |
| Madrigal Pharmaceuticals, Inc. | 387.02M |
| Merck & Co., Inc. | 12.51B |
| BioMarin Pharmaceutical, Inc. | 700.97M |
| Regeneron Pharmaceuticals, Inc. | 5.306B |